tm logo

Monitor this mark

View On USPTO

ESTYBON
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 28 May 2021

Last Applicant/ Owned by

Onconova Therapeutics, Inc.

375 Pheasant Run

Newtown

PA

18940

Serial Number

77833465 filed on 23rd Sep 2009

Registration Number

3868532 registered on 26th Oct 2010

in the Principal Register

Correspondent Address

Tara Aaron-Stelluto

Tara Aaron-Stelluto

611 Commerce Street, Suite 2630

Nashville TN 37203

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ESTYBON

pharmaceuticals, namely, drugs for the treatment of cancer, myelodysplastic syndromes, ovarian cancer, pancreatic cancers, solid tumors, and hematological diseases

Classification Information

Class [005]
Pharmaceutical Products

pharmaceuticals, namely, drugs for the treatment of cancer, myelodysplastic syndromes, ovarian cancer, pancreatic cancers, solid tumors, and hematological diseases

First Use Date in General

01st Jun 2010

First Use Date in Commerce

01st Jun 2010

Mark Details

Serial Number

No 77833465

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
14th Mar 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
14th Mar 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14th Mar 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28th May 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
26th Oct 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
21st Dec 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
11th Oct 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11th Oct 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11th Oct 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04th Aug 2016TEAS SECTION 8 & 15 RECEIVED